Dr. Kurian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-8500
Education & Training
Vanderbilt UniversityMPH, 2004 - 2006
Vanderbilt University Medical CenterResidency, Psychiatry, 2002 - 2006
Texas A&M; Health Science Center College of MedicineClass of 2002
University of Texas Southwestern Medical CenterResidency, Psychiatry
Certifications & Licensure
IL State Medical License 2024 - 2026
OK State Medical License 2024 - 2025
TX State Medical License 2006 - 2025
TN State Medical License 2003 - 2006- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression Start of enrollment: 2011 May 01
- Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression Start of enrollment: 2011 Jul 29
Publications & Presentations
PubMed
- 1 citationsReward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial.Michael A Giles, Crystal M Cooper, Manish K Jha, Cherise R Chin Fatt, Diego A Pizzagalli
Behavioral Sciences. 2023-07-25 - 9 citationsPatterns of Pre-Treatment Reward Task Brain Activation Predict Individual Antidepressant Response: Key Results from the EMBARC Randomized Clinical TrialKevin P. Nguyen, Cherise Chin Fatt, Alex Treacher, Cooper Mellema, Crystal Cooper
Biological Psychiatry. 2021-09-22 - 15 citationsDorsolateral Prefrontal Cortex and Subcallosal Cingulate Connectivity Show Preferential Antidepressant Response in Major Depressive Disorder.Cherise Chin Fatt, Crystal Cooper, Manish K. Jha, Sina Aslan, Bruce D. Grannemann
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2021-01-01
Journal Articles
- Pretreatment and Early-Treatment Cortical Thickness Is Associated with SSRI Treatment Response in Major Depressive DisorderElizabeth A Bartlett, Jie Yang, Benji T Kurian, Madhukar Trivedi, Ramin V Parsey, Myrna Weissman, Maurizio Fava, Joseph M Trombello, Melvin McInnis, Nature
Authored Content
- S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive DisorderApril 2018
- S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive DisorderApril 2018
- S132. Cerebral Blood Perfusion Predictors of Antidepressant Response in Major Depressive DisorderApril 2018
- S131. Resting State Functional Connectivity Patterns Differentially Predict Treatment Outcomes to Sertraline Versus Placebo in Patients with Major Depressive DisorderApril 2018
- Characterizing Anxiety Subtypes and the Relationship to Behavioral Phenotyping in Major Depression: Results from the EMBARC StudyApril 2018
- Characterizing Anxiety Subtypes and the Relationship to Behavioral Phenotyping in Major Depression: Results from the EMBARC StudyApril 2018
- Join now to see all
Press Mentions
Stoking a Discussion on How to Support Workplace Mental HealthMay 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
